Novel assays of thrombogenic pathogenicity in the antiphospholipid syndrome based on the detection of molecular oxidative modification of the major autoantigen β2-glycoprotein I

Beta 2 glycoprotein I is a substrate of thiol oxidoreductases

(2010) F. H. Passam et al.   BLOOD

Naturally occurring free thiols within  2-glycoprotein I in vivo: nitrosylation, redox modification by endothelial cells, and regulation of oxidative stress-induced cell injury

(2010) Y. Ioannou et al.   BLOOD

Oxidative stress enhances AP-1 and NF-κB-mediated regulation of β2-Glycoprotein I gene expression in hepatoma cells

(2010) Wen-Chin Chiu et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study

(2009) Rolf T Urbanus et al.   LANCET NEUROLOGY

Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients

(2008) R Cervera et al.   ANNALS OF THE RHEUMATIC DISEASES

β2-glycoprotein I inhibits vascular endothelial growth factor and basic fibroblast growth factor induced angiogenesis through its amino terminal domain

(2008) P. YU et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Systemic Lupus Erythematosus

(2008) Anisur Rahman et al.   NEW ENGLAND JOURNAL OF MEDICINE